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Abstract 
Experimental studies demonstrated a positive effect of administration of Nigella sativa L. (Black 
cumin) and its active chemical components on cancer and tumor through the antioxidant and anti-
cancer activity. This study aimed to determine the beneficial effect of the use of black cumin in patients 
with cancer and tumor. This systematic review includes 4 randomized controlled trials that investigated 
the effect of the administration of black cumin in human cancer. Articles were searched in PubMed, 
Cochrane library, Semantic scholar and directory of open access journal (DOAJ), open grey and grey 
literature report databases for studies from 1983 to 2020 before May using the following 
keywords, Nigella sativa, black cumin, cancer, tumor, etc. The results examined that N. sativa is much 
effective in treating breast cancer, gastrointestinal cancer, brain tumor, and acute myeloid 
leukemia. According to the limited evidence from the study, black cumin may have favorable effects on 
cancer and tumor. However, more research is needed on different types of cancer to confirm and 
establish the above findings.  
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1. Introduction 
Nigella sativa L. or black cumin has become one 
of those popular medicinal plants that have been used 
for centuries for health benefits. Nigella sativa L. 
belongs to the Ranunculaceae family and is an annual 
herb with 8–12-inch-high pinnate, stratified leaves [1]. 
New products are also advocated from natural 
sources, as it is estimated that more than 300,000 
herbal species exist globally among them only 15% 
have been explored for their pharmacological potential 
[2]. N. sativa, along with many medicinal plants 
(Ranunculaceae) has been considered as one of the 
most appreciated nutrient-rich herbs in the world's 
history, and numerous scientific studies are under its 
way to justify the typically claimed use of this species' 
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small seed [3,4]. N. sativa is an herbaceous plant with 
wonderful therapeutic effects, such as 
antihypertensive, gastro-protective, nephro-
protective, antioxidant, antimicrobial, Geno 
protective, neuroprotective, immunomodulatory, 
anti-inflammatory, hypoglycemic, hypolipidemic, 
anti-carcinogenic and hepato-protective [5,6].  
N. sativa seeds with some active components such 
as essential oil, thymoquinone, p-cymene, and thymol 
are very rich in the fixed oil, essential fatty acids, 
alkaloids, phytosterols, glycolipids and phospholipids, 
saponins, and essential oil components. 
Thymoquinone (TQ) is a cytotoxic agent in many 
human tumor cell lines that seem to be immune to 
particular multi drugs [7]. There is evidence that most 
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of N. sativa's therapeutic effects are due to the 
influence of TQ which has been the sativa's greatest 
bioactive component. Crude and TQ against non-
communicable diseases (cardiovascular disease, 
obesity, hypertension, diabetes, cancer, etc.) are 
beneficial from their seeds and oil, and communicable 
diseases (malaria, AIDS, hepatitis C virus, fungal, viral, 
parasitic infections, etc.) [8]. TQ had already observed 
pleiotropic anti-cancer effects, including chemo 
potentiation, anti-inflammation, immunomodulation, 
as well as radiosensitization [9].  
In addition to inducing apoptosis across several 
different cancers, TQ has been shown to inhibit 
numerous tumorigenic signaling nodes, such as those 
involved in cell proliferation, epithelial to 
mesenchymal shift, invasive cell migration, and 
metastasis [10]. In this study, it was aimed to show the 
positive effects of N. sativa against human cancer. 
 
2. Materials and Methods 
2.1 Literature search 
The reporting of this review follows the Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement. We searched PubMed, 
Cochrane library, Semantic scholar, and directory of 
open access journal (DOAJ) databases for studies 
from 1983 to 2020 before May. For gray articles, we 
searched open grey (www.opengrey.eu) and grey 
literature reports (www.greylit.org). The keywords 
used for searching (Nigella sativa OR Black cumin OR 
Black seed OR Kalonji) AND (Cancer OR Tumor OR 
Malignancy) to identify intervention studies 
investigating the effect of black cumin on cancer. 
 
2.2 Study selection and data extraction 
In this systematic review, we included published 
intervention studies (these include randomized 
controlled trials, clinical trials, and placebo-controlled 
trials), reporting the effect of black cumin on cancer 
and published in English). Trials were excluded if they 
did not meet the criteria above and were involved in 
animal studies or in vitro studies, did not use the 
interests of intervention or outcome. Two independent 
reviewers (MAH and AIC) screened the titles and 
abstracts of the initially identified studies to determine 
whether they would satisfy the selection criteria. Any 
disagreements about selection were resolved through 
consensus or consultation with a third author (TR). 
The data collection form included questions on the 
year of publication, geographic origin, types of 
intervention, doses, patients’ type and characteristics 




2.3 Quality assessment 
The quality of each study was assessed by 
following the Cochrane format [11] reported in Table 1. 
The quality assessed for each study are (1) quality of 
randomization, (2) quality of blinding, and (3) quality 
of the description of withdrawals and dropouts. 
 
3. Results 
We selected four human studies (Table 2) that 
described the effect of N. sativa on human cancer [12-
15]. In three days, Behnamfar et al. analyzed the 
incidence and magnitude of phlebitis, applying N. 
Sativa by a catheter upon the peripheral vein. In their 
research, they reported that the prevalence of phlebitis 
in the control group was optimum and that the 
occurrence of phlebitis in the intervention group was 
lowest during the 72 hours of the test, assuming that 
N. sativa oil seemed to have a massive effect on the 
intervention group [12]. Hussain et al. demonstrated 
the effect of applying N. sativa oil on acute myeloid 
leukemia. The primary result of this research 
concluded that at the end of 28 days, the severity of 
 
Figure 1: Flow diagram of study selection 
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(n =222); Databases: Cochrane library (9), PubMed 































Records after duplicates removed 
(n =203) 
Records screened 
(n = 203) 
Records excluded 
(n = 187) 
Not relevant outcome 
(171) 
Literature review (11) 
Full-text articles 
assessed for eligibility 
(n = 16) 
Full-text articles 
excluded, with reasons 
(n = 12) 
Not reported the effect 
of black cumin on 
cancer (9) 
Not use randomized 
controlled trial (3) 
Studies included in 
qualitative synthesis 
(n = 4) 
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Table 1. Assessment of study quality for selected studies 
 
Authors Randomization Blinding Outcome measured 











Adequate (6 times at 12 hours 
interval) 
None Not provided None 
Hussain et al., 
2019 
Adequate Open label Both primary and secondary 
Treatment: 
7.4% 
Not provided None 
Mousa et al., 
2017 
Adequate Unclear 
Incidence of febrile neutropenia and 
length of hospital stay 
None Not provided None 














Table 2. Characteristics of studies included for systematic review examining effect of N. sativa on cancer 
 
Authors Country Study design Subjects Measures 
Dose 
intake 







60 patients having 
gastrointestinal 
cancers, 30 in 
treated group, 30 in 
control group 







There is no significant 
difference between 
the groups in terms of 
phlebitis incidence 
and severity 
Result analyzed by 
Chi-square test, 










54 patients having 
acute myeloid 
leukemia, 27 in 
treated group, 27 in 
control group 





Scale (OMAS) score 
was significantly 
lower in  N. sativa oil 
group compared with 
control group 
Result analyzed by 
chi-square test, 























in  N. sativa seed 
group compared with 
control group 




Carlo exact test 
(MCP) 
and Fisher’s exact 
test (FEP) 
14 






62 patients having 
breast cancer, 31 in 
intervention group, 
31 in control group 
N. sativa gel 






The development of 
acute radiation 
dermatitis and moist 
desquamation were 
lower in   N. sativa 
gel compared with 
those who used the 
placebo 
Result analysed by 
the Kaplan-Meier 
method with the 
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oral mucositis was significantly lower in the 
N. sativa oil group compared with the control group. 
Indeed, the incidence of erythematic and ulceration 
among the N. sativa oil community was lower. At the 
end of 12 days, pain severity among the N. sativa oil 
group dropped considerably compared with the 
control group. The secondary outcome of this study 
mentioned that salivary TNF-a was substantially 
lowered by the use of N. sativa oil mouth rinse on day 
18 and day 28 compared to the control group but 
salivary IL-6 was not considerably different in the 
N. sativa oil control samples compared to the 
corresponding group (p>0.05) [13]. Mousa et al. in 
their study found that maximum children took N. 
sativa for 3-9 months (average of 6 months) and loss 
of body weight was less severe in the intervention 
group than the control group (p=0.048). The 
intervention group of children experienced less febrile 
neutropenia (2.2%) than the control group (19.3%). 
The percentage of febrile neutropenia among 
medulloblastoma (MB) and children with primitive 
neuroectodermal tumors were higher among the 
control group than the intervention group. In the case 
of hematological toxic effects, there have been 
statistically significant disparities in the occurrence of 
neutropenia (p=0.001) and febrile neutropenia 
(p=0.001) between both the intervention group and 
the control group, but the incidence of anemia, 
thrombocytopenia, and leucopenia was not 
significantly different in both groups [14].  
Rafati et al. established how acute radiation 
dermatitis might have been eliminated in breast 
cancer by applying N. sativa gel. The incidence of skin 
toxicity in the N. sativa gel group was significantly 
lower at weeks 3, 4, and 5 compared to the control 
group even though there were significant differences 
between the two groups in the size and severity of 
moist desquamation. The worst perception of pain 
among the control group was substantially higher than 
that of the N. sativa gel group (p<0.05). There was no 
dramatic difference in the skin-related quality of life 
between the two classes [15]. 
 
4. Discussion 
The present review showed the effects of black 
cumin on different types of cancer. Anticancer activity 
of N. sativa was described in a study where certain TQ 
(a chemical component of black cumin) had been used 
to manipulate phosphatase and tensin homolog 
(PTEN) expression and induce apoptosis in human 
breast cancer cells. In this study, it was found that TQ 
significantly inhibits the proliferation of DOX cells. It, 
therefore, triggered apoptosis and protein p53, and 
even some up-regulated PTEN by inhibiting the Akt 
pathway [16]. Another mouse study showed that TQ 
induced cytotoxicity and apoptosis, and also inhibited 
tumor growth [17]. TQ induces apoptosis and disrupts 
mitochondrial membrane potentials. It also activates 
the caspases 3, 8, and 9 in HL-60 cells to treat 
myeloblastic leukemia, thus showing its effect on 
myeloblastic leukemia [18]. TQ indicates significant 
cytotoxicity for cancer of such bladder. It prevents the 
rapid multiplication of cancer cells, and by activating 
caspases induces apoptosis. TQ's anticancer effect 
resulted in endoplasmic reticulum stress pathway 
activation and mitochondrial dysfunctions. It also 
boosted the Bcl-2 anti-apoptotic protein and blocked 
cytochrome C entrance [19]. TQ inhibited renal cell 
cancer (RCC) via cell migration, invasion, and 
epithelial-mesenchymal shift. This also increased the 
expression of E-cadherin and the level of hepatic 
kinase B1 phosphorylation was considerably 
upregulated following thymoquinone therapy [20, 21]. 
TQ protects against the development of prostate 
cancer. It was found to inhibit the growth of DU145 
and PC3 cells which caused prostate cancer by treating 
with TQ. TQ dramatically inhibits the DU145 and PC3 
cell migration (p<0.05). The expression of epithelial-
mesenchymal transition (EMT) markers in prostate 
cancer cells have also been repressed, and TGF-ß, 
Smad2, and Smad3 expression have also been 
minimized with TQ [22]. 
The article has some strengths and limitations. 
Using proper guidelines of the systematic review and 
quality assessment of the selected studies are the 
strengths of the articles. Some limitations of the article 
are only used article published in English and had full-
text availability. 
N. sativa component potential anticancer 
activities have been identified thousands of years ago 
but appropriate scientific research with this essential 
traditional medicine is a very recent story. According 
to the limited evidence from the study, black cumin 
may have favorable effects on human cancer and 
tumor. It is worth emphasizing further research work 
behind this because it is a safe and effective anticancer 
agent. In particular, researchers should evaluate the 
active compounds more broadly, as very few authentic 
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reports are available on the chemical composition of 
seeds or N. sativa exists. Also, more importance 
should be placed to investigate the appropriate 
molecular pathways of TQ and other components on 
different cancers as the current understandings are 
largely unclear. 
Regarding the potential benefits of N. sativa on 
cancer, the anti-carcinogenic effects of N. sativa 
remained assessed through restricted clinical trials 
lacking a placebo community. For ongoing studies, it 
was recommended that further double-blind, placebo-
controlled randomized clinical trials test the impact of 
N. sativa on cancer diagnosis and prevention. 
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